A Network Built on Shared Expertise
Melanoma research rarely advances through isolated effort. It moves forward because dermatologists in Rotterdam compare notes with oncologists in Vienna, because a trial site in Barcelona shares patient outcomes with a lab in Berlin, and because someone, somewhere, asks the right question at the right moment. This page introduces the institutions and researchers who make that exchange possible.
Our network spans university hospitals, dedicated cancer centers, and independent research groups across Europe. Some members bring decades of clinical trial experience; others contribute specialized diagnostic capabilities or access to patient populations that make specific studies feasible. What unites them is a commitment to rigorous, collaborative science and a willingness to share data, protocols, and hard-won insight rather than guard them.
What Membership Involves
- Active participation in multi-center clinical trials and translational studies
- Adherence to shared protocols for data collection, patient safety, and reporting
- Regular contribution to working groups focused on emerging melanoma subtypes and treatment resistance
- Access to a pooled body of clinical knowledge that no single institution could build alone
Researchers joining this directory range from principal investigators leading landmark trials to early-career clinicians contributing case data and fresh perspective. The listing itself is less a static roster than a living map of where melanoma expertise currently concentrates in Europe, and where it's growing.
If your institution is exploring whether this kind of collaboration fits your work, we'd rather have an honest conversation than a lengthy application process. Visit our contact page to start that discussion, or explore our research initiatives to see the kind of work this network makes possible.